Abstracts

Citation

Richard Brundage, Pharm.D., Ph.D., Mark W. Kline, M.D., Jane C. Lindsey, Sc.D., Terence Fenton, Ed.D., Courtney V. Fletcher, Pharm.D. Pharmacokinetics (PK) Of Saquinavir (SQV) and Nelfinavir (NFV) In A Twice-Daily (BID) Regimen In HIV-Infected Children.

Citation

Richard Brundage, Pharm.D., Ph.D., Mark W. Kline, M.D., Jane C. Lindsey, Sc.D., Terence Fenton, Ed.D., Courtney V. Fletcher, Pharm.D. Pharmacokinetics (PK) of Saquinavir (SQV) and Nelfinavir (NFV) in a Twice-Daily (BID) Regimen in HIV-Infected Children.

Citation

Mark Mirochnick, M.D., George E. Kafulafula, MMED, F.A.C.O.G., M.B.B.S., Regis Kreitchmann, M.D., Jorge Pinto, M.D., D.Sc., Teresa Parsons, Ph.D., Karin Alvarenga-Hyldgaard Nielsen, M.D., M.P.H., Paul Sato, M.D., M.P.H., Lynne M. Mofenson, M.D., F.A.A.P., Mary Glenn Fowler, M.D., M.P.H. Pharmacokinetics (PK) of Tenofovir Disoproxil Fumarate (TDF) After Administration to HIV-1 Infected Pregnant Women and their Newborns. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Jorge Pinto, M.D., D.Sc., Brian Robbins, Ph.D., Jie (Ellen) Chen, M.S., Leslie Serchuck, M.D., Edmund Capparelli, Pharm.D., Ram Yogev, M.D., Paul Palumbo, M.D., John H. Rodman, Pharm.D., Barbara E. Heckman, B.S., Ellen Gould Chadwick, M.D. Pharmacokinetics and 24-week efficacy and safety of lopinavir/ritonavir in HIV-1-infected infants < 6 weeks of age. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Tim Roy Cressey, B.Sc., Ph.D., Kulkanya Chokephaibulkit, M.D., Nirun Vanprapar, M.D., M.Sc., Edmund Capparelli, Pharm.D., Tawee Chotpitayasunondh, M.D., Wasana Prasitsuebsai, M.D., Kenneth McIntosh, M.D., Petronella Muresan, M.S., Ram Yogev, M.D. Pharmacokinetics and safety of a novel antiretroviral pediatric fixed-dose combination versus the liquid formulations in HIV-infected children in Thailand: pilot stage analysis. Presented at: 5th World Congress of The World Society For Pediatric Infect.

Citation

Pharmacokinetics and Safety of A Novel Chewable Pediatric Fixed-Dose Combination (FDC) of Zidovudine (ZDV), Lamivudine (3TC), Nevirapine (NVP): in HIV-Infected Thai Children. Presented at: 2nd International Workshop on HIV Pediatrics.

Citation

F. Boucher. Pharmacokinetics and Safety of Azidothymidine (AZT) in Infants Less Than Three Months Old, Exposed at Birth to HIV.

Citation

Anneke C. Hesseling, Elin M. Svensson, Paula Britto, Jennifer A. Hughes, Pauline Howell, Tumelo Moloantoa, Sarah Bradford, Mattie Bartlett, Tafadzwa Kasambira, Sai Majji, Anne-Marie Demers, H. Simon Schaaf, IMPAACT P1108 Protocol Team. Pharmacokinetics and Safety of Bedaquiline in Infants, Children, and Adolescents with Rifampicin-Resistant Tuberculosis. Presented at: The Union World Conference on Lung Health; 2024 Nov 15.

Citation

Jennifer A. Hughes, Flynn McMorrow, Kristina M. Brooks, Lee Fairlie, Alice Stek, Mark Mirochnick, Lubbe Wiesner, Kathleen George, Kevin Knowles, Anneke C. Hesseling, Eric Decloedt, Ahizechukwu C. Eke. Pharmacokinetics and safety of clofazimine in women treated for rifampicin-resistant tuberculosis during pregnancy and the postpartum period. Presented at: The Union World Conference on Lung Health; 2025 Nov 21.

Citation

Nancy Wade, M.D., M.P.H., Jashvant D. Unadkat, Ph.D., Sharon Huang, M.S., David E. Shapiro, Ph.D., Anita A. Mathias, Ph.D., Salih Yasin, M.D., Gregory Ciupak, B.A., Heather D. Watts, M.D., Issac Delke, M.D., Mobeen H. Rathore, M.D., Jane Hitti, M.D., M.P.H., Lisa M. Frenkel, M.D., Renee Samelson, M.D., Mary Smith, R.N., Lynne M. Mofenson, M.D., F.A.A.P., Sandra K. Burchett, M.D., M.S. Pharmacokinetics and Safety of d4T and 3TC in HIV-infected Pregnant Women and their infants ( PACTG 332).